New endpoints may be selected because they displayed a trend towards significance, while other candidate endpoints may have been examined but not selected or reported because they failed to display a desirable trend; this increases the chance of false positive (type 1) errors.
← all excerpts
When and how can endpoints be changed after initiation of a randomized clinical trial?
1
—
—